Drugs.com - New Drug Approvals

FDA Approves Mezofy (aripiprazole) Oral Film for the Treatment of Schizophrenia

Seoul, Korea -- April 16, 2025 -- CMG Pharmaceuticals, an affiliate of Cha Biotech, announced on the 16th that it had received product approval for the schizophrenia treatment drug Mezofy (formerly Depibzo) from the U.S. Food and Drug Administration...

May 4, 2025 - 22:20
 0
FDA Approves Mezofy (aripiprazole) Oral Film for the Treatment of Schizophrenia
Seoul, Korea -- April 16, 2025 -- CMG Pharmaceuticals, an affiliate of Cha Biotech, announced on the 16th that it had received product approval for the schizophrenia treatment drug Mezofy (formerly Depibzo) from the U.S. Food and Drug Administration...
Read More

Tags:

Previous Article

Footwear Brands Including Nike and Adidas Ask Trump for Tariff Exemption

Next Article

Costa Rica achieved the highest EV market share in the Americas for the third co...

Related Posts

FDA Grants Isturisa (osilodrostat) Expanded Indication for the Treatment of Endogenous Hypercortisolemia in Patients with Cushing’s Syndrome

FDA Grants Isturisa (osilodrostat) Expanded Indication ...

Apr 23, 2025  0

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

scPharmaceuticals Announces FDA Approval of Supplementa...

Apr 26, 2025  0

FDA Approves Atzumi (dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine

FDA Approves Atzumi (dihydroergotamine) Nasal Powder fo...

May 1, 2025  0